Clinical Trial Update: PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial reports on different Paliperidone Extended-Release dosing regimens and the clinical response in adults with acute schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone Extended Release (paliperidone extended-release)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-03-05